Sustainability, affordability, and equity of corporate drug donations: the case of Malarone.
Shretta
R
R
Kenya Medical Research Institute/Wellcome Trust Collaborative Programme, Nairobi. rima@wtrl.or.ke
Brugha
R
R
Robb
A
A
Snow
R W
RW
D000962:Antimalarials / Q000191:economics*; D053626:Atovaquone; D002608:Charities / Q000191:economics*; D003906:Developing Countries; D004338:Drug Combinations; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D007630:Kenya; D009285:Naphthoquinones / Q000191:economics*; D002727:Proguanil / Q000191:economics*
D000962:Antimalarials; D004338:Drug Combinations; D009285:Naphthoquinones; C109496:atovaquone, proguanil drug combination; D002727:Proguanil; D053626:Atovaquone